JVAIX | VIVIX | JVAIX / VIVIX | |
Total Expense Ratio | 0.69 | 0.04 | 1,725% |
Annual Report Gross Expense Ratio | 0.69 | 0.04 | 1,725% |
Fund Existence | 20 years | 27 years | - |
Gain YTD | -2.048 | -0.942 | 218% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 3000000 | 5000000 | 60% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.55B | 184B | 5% |
Annual Yield % from dividends | 1.61 | 2.35 | 69% |
Returns for 1 year | -1.42 | 5.12 | -28% |
Returns for 3 years | -3.61 | 20.66 | -17% |
Returns for 5 years | 37.91 | 72.19 | 53% |
Returns for 10 years | 34.39 | 96.21 | 36% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ARTQX | 14.79 | 0.11 | +0.75% |
Artisan Mid Cap Value Investor | |||
DIECX | 41.83 | N/A | N/A |
BNY Mellon International Core Equity C | |||
LICRX | 16.06 | N/A | N/A |
Lord Abbett International Equity R3 | |||
FACTX | 47.46 | N/A | N/A |
Fidelity Advisor Health Care M | |||
WGIFX | 64.76 | -0.04 | -0.06% |
American Funds Capital World Gr&Inc F2 |